Membership benefits

    • Participation in working groups to proactively shape future policies

      – Working group on the upcoming implementing and delegated acts related to MDR/IVDR and Medicinal Product Directive 2001/83 affecting combined products (drug&device – drug&CDx)

      – Working group for personalized healthcare (PHC)

    • Access to a platform with top level stakeholder interactions on innovative healthcare solutions

    • Access to scientific network and knowledge pool on combined products

    • Reduced fees for participation in MPP annual conference and MPP trainings